OTC Markets OTCPK - Delayed Quote USD

Nippon Shinyaku Co., Ltd. (NPNKF)

25.58
0.00
(0.00%)
At close: June 12 at 8:00:00 PM EDT
Loading Chart for NPNKF
  • Previous Close 25.58
  • Open 26.08
  • Bid 22.94 x 30000
  • Ask 26.89 x 40000
  • Day's Range 26.08 - 26.08
  • 52 Week Range 23.58 - 55.55
  • Volume 90
  • Avg. Volume 184
  • Market Cap (intraday) 1.724B
  • Beta (5Y Monthly) -0.28
  • PE Ratio (TTM) 7.64
  • EPS (TTM) 3.35
  • Earnings Date Aug 5, 2025 - Aug 11, 2025
  • Forward Dividend & Yield 0.87 (3.39%)
  • Ex-Dividend Date Sep 29, 2025
  • 1y Target Est --

Nippon Shinyaku Co., Ltd. manufactures and sells pharmaceuticals and foodstuffs in Japan and internationally. The company operates through Pharmaceuticals and Functional Food Business segments. Its Pharmaceuticals Business segment offers drugs in the fields of urology, hematology, intractable and rare diseases, gynecology, and other diseases. The company's Functional Food Business segments provides health food ingredients, preservatives, protein preparations, and sports and supplements. The company in the Strategic Partnership with Nippon Shinyaku will develop and commercialize for Mucopolysaccharidosis. Nippon Shinyaku Co., Ltd. was founded in 1911 and is headquartered in Kyoto, Japan.

www.nippon-shinyaku.co.jp

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: NPNKF

View more

Performance Overview: NPNKF

Trailing total returns as of 6/13/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

NPNKF
496.62%
Nikkei 225 (^N225)
5.16%

1-Year Return

NPNKF
3,315.85%
Nikkei 225 (^N225)
2.29%

3-Year Return

NPNKF
20,738,412.00%
Nikkei 225 (^N225)
40.19%

5-Year Return

NPNKF
70.25%
Nikkei 225 (^N225)
69.62%

Compare to: NPNKF

Select to analyse similar companies using key performance metrics; select up to four stocks.

Statistics: NPNKF

View more

Valuation Measures

Annual
As of 6/13/2025
  • Market Cap

    1.72B

  • Enterprise Value

    1.33B

  • Trailing P/E

    7.63

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.55

  • Price/Book (mrq)

    1.01

  • Enterprise Value/Revenue

    1.19

  • Enterprise Value/EBITDA

    4.49

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    20.32%

  • Return on Assets (ttm)

    8.10%

  • Return on Equity (ttm)

    13.92%

  • Revenue (ttm)

    160.23B

  • Net Income Avi to Common (ttm)

    32.56B

  • Diluted EPS (ttm)

    3.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    55.24B

  • Total Debt/Equity (mrq)

    1.10%

  • Levered Free Cash Flow (ttm)

    -1.67B

Research Analysis: NPNKF

View more

Company Insights: NPNKF

Research reports: NPNKF

View more

People Also Watch